Forma Therapeutics Holdings, Inc(NASDAQ:FMTX) 
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatm...
Website: https://www.formatherapeutics.com/
Founded: 2007
Full Time Employees: 114 (May 2021)
CEO: Frank D. Lee
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2022-04-20
P
O 8.32
H 8.83
L 8.15
C 8.38
V 556,935
10EMA 8.38
20EMA 8.38
60EMA 8.38
120EMA 8.38
250EMA 8.38